ARG46310

anti-NALP4 antibody

anti-NALP4 antibody for Western blot and Human,Mouse

Overview

Product Description Rabbit Polyclonal antibody recognizes NALP4
Tested Reactivity Hu, Ms
Tested Application WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name NALP4
Antigen Species Human
Immunogen A 13 amino acid synthetic peptide within aa. 330 - 380 of human NALP4.
Conjugation Un-conjugated
Alternate Names NLRP4; NLR family, pyrin domain containing 4; NALP4; CT58; PAN2; RNH2; NALP4; PYPAF4; CLR19.5; NACHT; LRR and PYD domains-containing protein 4; PAAD and NACHT-containing protein 2; CT58

Application Instructions

Application Suggestion
Tested Application Dilution
WBAssay-dependent
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity chromatography purified
Buffer PBS and 0.02% Sodium azide.
Preservative 0.02% Sodium azide
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -360°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 147945 Human NLRP4

Swiss-port # Q96MN2 Human NACHT, LRR and PYD domains-containing protein 4

Gene Symbol NLRP4
Gene Full Name NLR family, pyrin domain containing 4
Background The protein encoded by this gene is a member of the nucleotide-binding and leucine-rich repeat receptor (NLR) family, and is predicted to contain an N-terminal pyrin effector domain (PYD), a centrally-located nucleotide-binding and oligomerization domain (NACHT) and C-terminal leucine-rich repeats (LRR). This gene product has a demonstrated role as a negative regulator of autophagy and type I interferon signaling pathways as a result of protein interactions with its NACHT domain. The PYD domain has also been shown to be important in the inhibition of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells). [provided by RefSeq, Dec 2016]
Function May be involved in inflammation and recognition of cytosolic pathogen-associated molecular patterns (PAMPs) not intercepted by membrane-bound receptors. Acts as a negative regulator of the type I interferon signaling pathway by serving as an adapter to promote DTX4-mediated ubiquitination of activated TBK1, and its subsequent degradation. Suppresses NF-kappaB induction by the cytokines TNFA and IL1B, suggesting that it operates at a point of convergence in these two cytokine signaling pathways. [UniProt]
Calculated MW 113 kDa